CAM
INDV icon

Claret Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Claret Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.1M Sell
685,523
-21,744
-3% -$789K 3.03% 7
2026
Q1 		$21.6M Buy
+707,267
New +$23.4M 2.58% 11
2025
Q4 		– Sell
-784,588
Closed -$18.9M – 402
2025
Q3 		$18.9M Buy
784,588
+40,306
+5% +$843K 2.25% 13
2025
Q2 		$11M Sell
744,282
-937
-0.1% -$10.9K 1.42% 16
2025
Q1 		$7.1M Sell
745,219
-3,267
-0.4% -$34.3K 1.02% 25
2024
Q4 		$9.3M Buy
+748,486
New +$7.7M 1.47% 18

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Claret Asset Management's INDV Position: Q2 2026 in Review

Claret Asset Management reduced its Indivior Pharmaceuticals (INDV) stake by 3.1% in Q2 2026, selling an estimated $789K and leaving 685,523 shares worth $28.1M. The position accounts for 3.03% of the portfolio, ranked #7.

Claret Asset Management first reported a position in INDV in Q4 2024 and has held it in 6 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Claret Asset Management held 685,523 shares of Indivior Pharmaceuticals worth $28.1M as of Q2 2026.
  • Claret Asset Management sold 21,744 Indivior Pharmaceuticals shares in Q2 2026, an estimated $789K.
  • Indivior Pharmaceuticals made up 3.03% of Claret Asset Management's portfolio in Q2 2026, its #7 holding.
  • Claret Asset Management first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.